
<p>Inflammatory Marker Predicts Outcome of Oral Squamous Cell Carcinoma Receiving Chemo-Radiotherapy</p>
Author(s) -
Wei Sun,
Meng Gao,
Guohong Hu,
Xun Yuan
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s277927
Subject(s) - nomogram , medicine , neutrophil to lymphocyte ratio , oncology , lymphocyte , radiation therapy , lactate dehydrogenase , basal cell , gastroenterology , biology , biochemistry , enzyme
Inflammation is involved in the progression of oral squamous cell carcinoma. We therefore postulate that a blood-based inflammatory marker, the neutrophil-to-lymphocyte ratio, could help to predict the prognosis in patients with oral squamous cell carcinoma receiving chemo-radiotherapy, and build a prognostic nomogram.